nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0678	0.0678	CcSEcCtD
Clindamycin—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.0617	0.0617	CcSEcCtD
Clindamycin—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0518	0.0518	CcSEcCtD
Clindamycin—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.0511	0.0511	CcSEcCtD
Clindamycin—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.049	0.049	CcSEcCtD
Clindamycin—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.0472	0.0472	CcSEcCtD
Clindamycin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0378	0.0378	CcSEcCtD
Clindamycin—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0361	0.0361	CcSEcCtD
Clindamycin—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0326	0.0326	CcSEcCtD
Clindamycin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0274	CcSEcCtD
Clindamycin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0273	CcSEcCtD
Clindamycin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0255	0.0255	CcSEcCtD
Clindamycin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.0246	0.0246	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0198	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0193	CcSEcCtD
Clindamycin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0178	CcSEcCtD
Clindamycin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0163	CcSEcCtD
Clindamycin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0155	CcSEcCtD
Clindamycin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Clindamycin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Clindamycin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0148	CcSEcCtD
Clindamycin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0141	CcSEcCtD
Clindamycin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Clindamycin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Clindamycin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Clindamycin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0122	CcSEcCtD
Clindamycin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Clindamycin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Clindamycin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Clindamycin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Clindamycin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Clindamycin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Clindamycin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Clindamycin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00973	0.00973	CcSEcCtD
Clindamycin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00948	0.00948	CcSEcCtD
Clindamycin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0092	0.0092	CcSEcCtD
Clindamycin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00901	0.00901	CcSEcCtD
Clindamycin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0086	CcSEcCtD
Clindamycin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0082	CcSEcCtD
Clindamycin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0081	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00794	0.00794	CcSEcCtD
Clindamycin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00793	0.00793	CcSEcCtD
Clindamycin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Clindamycin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Clindamycin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00752	0.00752	CcSEcCtD
Clindamycin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00731	0.00731	CcSEcCtD
Clindamycin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00727	CcSEcCtD
Clindamycin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00727	CcSEcCtD
Clindamycin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00678	CcSEcCtD
Clindamycin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0066	CcSEcCtD
Clindamycin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00651	0.00651	CcSEcCtD
Clindamycin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00629	CcSEcCtD
Clindamycin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00608	CcSEcCtD
Clindamycin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00585	CcSEcCtD
Clindamycin—Rash—Riluzole—amyotrophic lateral sclerosis	0.0058	0.0058	CcSEcCtD
Clindamycin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0058	0.0058	CcSEcCtD
Clindamycin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00576	CcSEcCtD
Clindamycin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00546	CcSEcCtD
